Abstract
Background Jurisdictions worldwide ramped down ophthalmic surgeries to mitigate the effects of coronavirus disease 2019 (COVID-19), creating a global surgical backlog. We sought to predict the long-term impact of COVID-19 on ophthalmology surgical care delivery.
Methods This is a population-based and a microsimulation modelling study. Provincial administrative data from January 2019 to May 2021 was used to estimate the backlog size and wait-times following the COVID-19 pandemic. For the post-pandemic recovery phase, we estimated the resources required to clear the backlog of patients accumulated on the waitlist during the pandemic.
Results A total of 56,923 patients were on the waitlist in the province of Ontario awaiting non-emergency ophthalmic surgery as of March 15, 2020. The number of non-emergency surgeries performed in the province decreased by 45-98% from March to May 2020, and 48-80% from April to May 2021 compared to the same months in 2019. By 2 years and 3 years, the overall estimated number of patients awaiting surgery grew by 129% and 150%, respectively. The estimated mean wait-time for patients for all subspecialty surgeries increased to 282 (SD 91) in March 2023 compared to 94 days (SD 97) in 2019. The provincial monthly additional resources required to clear the backlog by March 2023 was estimated to be a 34% escalation from the pre-pandemic volumes (4,626 additional surgeries).
Interpretation The magnitude of the ophthalmic surgical backlog from COVID-19 has important implications for the recovery phase. The estimates from this microsimulation modelling can be adapted to other jurisdictions to assist with recovery planning for vision saving surgeries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
1. Tina Felfeli has received grants from the Vanier Canada Graduate Scholarship, Canada Graduate Scholarship-Masters, the Vision Science Research Program, and Postgraduate Medical Education Research Awards as part of postsecondary research funding. 2. This research was supported by COVID-19 Rapid Research Funding (C-291- 2431272-SANDER) through the Ontario Ministry of Health, Ontario Together grant. This research was also supported, in part, by a Canada Research Chair in Economics of Infectious Diseases grant held by Beate Sander (CRC-950-232429). The funding organizations had no role in the design or conduct of this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Waiver of ethics review for use of de-identified population-level data for the model was permitted by the University of Toronto Institutional Review Board for Human Subjects Research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding/Support: 1. Tina Felfeli has received grants from the Vanier Canada Graduate Scholarship, Canada Graduate Scholarship-Masters, the Vision Science Research Program, and Postgraduate Medical Education Research Awards as part of postsecondary research funding.
2. This research was supported by COVID-19 Rapid Research Funding (C-291- 2431272-SANDER) through the Ontario Ministry of Health, Ontario Together grant. This research was also supported, in part, by a Canada Research Chair in Economics of Infectious Diseases grant held by Beate Sander (CRC-950- 232429).
The funding organizations had no role in the design or conduct of this research.
Conflict of Interest: No conflicting relationship exists for any author.
Meeting Presentation: Partial aspects of this study was presented at the following virtual meetings: 1. Institute of Health Policy, Management and Evaluation (IHPME) Annual Research Meeting held on November 20, 2020 in Canada
2. Health Technology Research Annual Meeting held on February 5, 2021 in Brazil
Minor details in manuscript text updated.
Data Availability
Data is not available for external access.
